跳至主要内容
临床试验/IRCT2012110411362N1
IRCT2012110411362N1已完成未知

Assessment of serum levels of adiponectin and asymmetric dimethylarginine in patients with persistent and permanent atrial fibrillation following supplementation with fish oil

School of Public Health, Tehran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 81 years(—)
性别
All

入选标准

  • postmenopausal women; men; above 50 years old; BMI higher than 25 kg/m2; patients without hyperthyroidism; patients without heart valve disorders; patients did not underwent coronary artery bypass surgery in the last three months; patients without heart failure of class IV; patients without history of alcohol abuse; not started taking in fish oil supplement within the three months before intervention; patients without allergy to fish oil
  • Exclusion criteria: patients who stops taking supplement or placebo; patients who lose interest in participating in the study; patient who undergo coronary bypass

排除标准

  • 未提供

研究者

发起方
School of Public Health, Tehran University of Medical Sciences

相似试验